Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial

RG Bretzel, U Nuber, W Landgraf, DR Owens, Clare Bradley, T Linn

Research output: Contribution to journalArticlepeer-review

324 Downloads (Pure)
Original languageEnglish
Pages (from-to)1073-1084
Number of pages12
JournalThe Lancet
Issue number9618
Publication statusPublished - 29 Mar 2008

Cite this